Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Index funds offer broad diversification with low fees, making them a solid foundation for retirement portfolios. This guide outlines how to choose and allocate them.
25,366 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
A new humanoid robot from a major player has people talking. This article breaks down what a rival with a familiar lo...
AI-related debt now accounts for about 15% of the debt corporate bond market, signaling a shift that could alter risk...
A prediction-market operator flagged unusual bets tied to a former U.S. representative ahead of a State of the Union ...
Oklo has faced a challenging six months as the stock trended lower with little revenue to show. This article explores...
GE Vernova's stock slide today highlights how AI data center growth and sector volatility interact with broader marke...
Intel prepares for a pivotal investor update, and investors want to know whether buying now makes sense. This guide b...
A fresh stake from Cross Staff Investments in the Akre Focus ETF could signal a manager’s confidence in Akre’s approa...
In March 2026, Anduril landed a long-term Army contract valued up to $20 billion, moving defense tech from pilots to ...
Curious about XRP’s future? This article lays out a practical 5-year forecast with three scenarios and clear steps yo...
Ethereum faces another wave of selling pressure as macro tensions, on-chain signals, and sentiment converge. This gui...
When veterans return with their first original album in years, the headlines focus on the music. What truly stands ou...